Committee Approves Ananich Bill to Combat Student Overdoses

Michigan would be 8th state to allow access to lifesaving drug in schools

LANSING, Mich. — Today the Senate Health Policy Committee approved bipartisan legislation from Senate Democratic Leader Jim Ananich (D– Flint) that would allow schools to stock naloxone, a medication that helps combat drug overdoses.

“Saving lives must be our ultimate goal as we tackle this epidemic on all fronts, including prevention, treatment and enforcement,” said Sen. Ananich, a member of the Michigan Prescription Drug and Opioid Abuse Task Force. “Legislation like this gives our schools one more tool to keep our students safe.”

Expanding access to Naloxone (Narcan), an antidote used to treat an opioid overdose in an emergency situation, was one of the many recommendations of the task force.

Under Senate Bill 805, introduced by Sen. Ananich, and Senate Bill 806, introduced by Sen. Dale Zorn (R–Ida), if a school district decides to obtain the drug, the bills would outline some specific requirements, including:

According to the Michigan Department of Community Health, drug overdoses are now the leading cause of injury deaths in the U.S. and incidents have nearly quadrupled in Michigan since 1999. Four counties — Monroe, Genesee, Kent and Grand Traverse — have higher rates of overdoses than the state average.

Currently, seven other states — Delaware, Illinois, Kentucky, Massachusetts, New York, Rhode Island and Vermont — have already enacted laws similar to this legislation. If passed by the legislature, Michigan would become the eighth state in the country to allow school personnel access to the lifesaving drug.


More news:

Sen. Ananich on open carry ban at polling locations Sen. Ananich on MDHHS Epidemic Order Sen. Ananich on Supreme Court’s Emergency Powers Ruling

Subscribe to my e-newsletter!

Sign up to be the first to know what I'm doing to build a thriving community and fight for you.

First Name is required

Last Name is required

Email Address is required

Zip Code is required

We take your privacy seriously. View our Privacy Policy.